Skip to main navigation Skip to search Skip to main content

Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets

  • D Vesole
  • , E Stadtmauer
  • , L.T Goodnough
  • , S Coutre
  • , F Howard
  • , J.-S Lin
  • , M.G Conlan
  • , Frank D. Howard

Research output: Contribution to conferencePosterpeer-review

Original languageAmerican English
Pages85
DOIs
StatePublished - Feb 1 2004

Disciplines

  • Endocrinology, Diabetes, and Metabolism
  • Immunology and Infectious Disease
  • Medicine and Health Sciences

Cite this